COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology
Recruiting
Observational Study
Pediatric Respiratory Diseases
COVID
Fatigue Post Viral
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- Up to 18
- Sex
- Any
- Study type
- Observational
- Participants needed
- 350 (estimated)
- Sponsor
- University Hospital, Akershus · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Prospective cohort study of COVID-19 infection among children in Norway.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Suspected covid-19 infection and age 0-18 years
Exclusion Criteria:
Age \>18 years
Contacts